Evaluating the Efficacy of Surfactants, Curosurf ,Survanta and Alveofact, in Respiratory Distress Syndrome in Infants
Not Applicable
- Conditions
- eonatal respiratory distress.Respiratory distress syndrome of newborn
- Registration Number
- IRCT201411028680N5
- Lead Sponsor
- Vice Chancellor for research of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 165
Inclusion Criteria
Infants born at a gestational age of 36 weeks or less
Exclusion criteria: congenital anomalies, birth asphyxia (Apgar score less than 4 at 5 minutes) and gestational age over 36 weeks
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Base exhess change. Timepoint: After intervention. Method of measurement: Blood gas analysis.;Pco2 Change. Timepoint: After intervention. Method of measurement: Blood gas analysis.;Duration of oxygen dependency. Timepoint: Up to 7 daye after intervention. Method of measurement: Oxygen Saturation analysis with pulsoxymetery.;CPAP Failure. Timepoint: After intrvention. Method of measurement: Blood gas analysis.
- Secondary Outcome Measures
Name Time Method Intraventricular hemorrhage. Timepoint: Up to 7 days after intervention. Method of measurement: Brain sonography.;Patent ductus arteriosus. Timepoint: Up to 7 days after intervention. Method of measurement: Echocardiography.;Broncho pulmonary dysplasia. Timepoint: up to 28 daye old. Method of measurement: Chest X-ray.;Mortality. Timepoint: Up to 28 days after intervention. Method of measurement: clinical finding.